Homburger is acting as legal advisor for Siegfried Holding in the placement of a CHF 200 million 0.20% Senior Bond due 2026. The bonds will be admitted for trading and listing on the SIX Swiss Exchange. The closing is expected to be June 15, 2021. UBS acting as lead manager.
Homburger team is led by partner Benjamin Leisinger (pictured) along with counsel Eduard De Zordi and paralegal Ganna Schneuwly (all Capital Markets).
Siegfried offers pharmaceutical industry partners a comprehensive range of services. Once a fully integrated pharmaceutical company, Siegfried will provide both the drug substance and the drug product development and production capabilities.